Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Short Interest Down 20.3% in May

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 14,180,000 shares, a decrease of 20.3% from the April 30th total of 17,790,000 shares. Based on an average daily trading volume, of 1,420,000 shares, the short-interest ratio […]

Related Keywords

Pascal Touchon ,Zurcher Kantonalbank Zurich Cantonalbank ,Nasdaq ,First Republic Investment Management Inc ,Nisa Investment Advisors ,Ef Hutton Acquisition Co ,Us Bancorp ,Atara Biotherapeutics Inc ,Tower Research Capital ,Get Rating ,Research Capital ,Investment Advisors ,Republic Investment Management ,Kantonalbank Zurich Cantonalbank ,Atara Biotherapeutics ,Nasdaq Atra ,Tatra ,Medical ,Stocks ,Options ,Put ,Call ,